These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24611576)

  • 21. Muscle weakness and speech in oculopharyngeal muscular dystrophy.
    Neel AT; Palmer PM; Sprouls G; Morrison L
    J Speech Lang Hear Res; 2015 Feb; 58(1):1-12. PubMed ID: 25321879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD).
    Melkus G; Sampaio ML; Smith IC; Rakhra KS; Bourque PR; Breiner A; Zwicker J; Lochmüller H; Brais B; Warman-Chardon J
    Neuromuscul Disord; 2023 Jan; 33(1):24-31. PubMed ID: 36462961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy.
    de Swart BJ; van der Sluijs BM; Vos AM; Kalf JG; Knuijt S; Cruysberg JR; van Engelen BG
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):266-8. PubMed ID: 16421137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands.
    Alonso-Pérez J; de León Hernández JC; Pérez-Pérez H; Mendoza-Grimón MD; Gutierrez-Martinez AJ; Hadjigeorgiou I; Montón-Álvarez F; González-Quereda L; Alonso-Jimenez A; Suárez-Calvet X; Díaz-Manera J
    Eur J Neurol; 2022 May; 29(5):1488-1495. PubMed ID: 35112761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Swallowing, Chewing and Speaking: Frequently Impaired in Oculopharyngeal Muscular Dystrophy.
    Kroon RHMJM; Horlings CGC; de Swart BJM; van Engelen BGM; Kalf JG
    J Neuromuscul Dis; 2020; 7(4):483-494. PubMed ID: 32804098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of rare recessive oculopharyngeal muscular dystrophy (OPMD) coexisting with hereditary neuropathy with liability to pressure palsies (HNPP).
    Marsh EA; Robinson DO
    Clin Neurol Neurosurg; 2008 May; 110(5):525-8. PubMed ID: 18358598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
    Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
    Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living with oculopharyngeal muscular dystrophy: a phenomenological study.
    Krause-Bachand J; Koopman W
    Can J Neurosci Nurs; 2008; 30(1):35-9. PubMed ID: 18432080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy.
    Davies JE; Sarkar S; Rubinsztein DC
    Hum Mol Genet; 2006 Jan; 15(1):23-31. PubMed ID: 16311254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dutch patients' perspective on oculopharyngeal muscular dystrophy: A questionnaire study on fatigue, pain and impairments.
    van der Sluijs BM; Knoop H; Bleijenberg G; van Engelen BG; Voermans NC
    Neuromuscul Disord; 2016 Mar; 26(3):221-6. PubMed ID: 26948710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oculopharyngeal Muscular Dystrophy, an Often Misdiagnosed Neuromuscular Disorder: A Southern California Experience.
    Goyal NA; Mozaffar T; Chui LA
    J Clin Neuromuscul Dis; 2019 Dec; 21(2):61-68. PubMed ID: 31743248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oculopharyngeal muscular dystrophy - an under-diagnosed disorder?
    Rüegg S; Lehky Hagen M; Hohl U; Kappos L; Fuhr P; Plasilov M; Müller H; Heinimann K
    Swiss Med Wkly; 2005 Oct; 135(39-40):574-86. PubMed ID: 16333769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gradual onset of dysphagia: a study of patients with oculopharyngeal muscular dystrophy.
    Young EC; Durant-Jones L
    Dysphagia; 1997; 12(4):196-201. PubMed ID: 9294939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-reported disease burden in oculopharyngeal muscular dystrophy.
    Kurtz NS; Cote C; Heatwole C; Gagnon C; Youssof S
    Muscle Nerve; 2019 Dec; 60(6):724-731. PubMed ID: 31531865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The requirement for a disease-specific patient-reported outcome measure of dysphagia in oculopharyngeal muscular dystrophy.
    Côté C; Gagnon C; Youssof S; sKurtz N; Brais B
    Muscle Nerve; 2019 Apr; 59(4):445-450. PubMed ID: 30575974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.
    Fischmann A; Gloor M; Fasler S; Haas T; Rodoni Wetzel R; Bieri O; Wetzel S; Heinimann K; Scheffler K; Fischer D
    J Neurol; 2011 Jul; 258(7):1333-40. PubMed ID: 21340522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
    Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oculopharyngeal muscular dystrophy associated with dementia.
    Mizoi Y; Yamamoto T; Minami N; Ohkuma A; Nonaka I; Nishino I; Tamura N; Amano T; Araki N
    Intern Med; 2011; 50(20):2409-12. PubMed ID: 22001477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.